The major aim of this research project is to accelerate the development of the SORT1+ oncology platform. This novel platform is based on a new proprietary peptide targeting Sortilin, a key scavenging receptor. Sortilin has been reported to play a role in cell survival and in the progression of human cancers. For instance, Sortilin expression […]
Read More